share_log

Appili Therapeutics Inc: REPORT OF EXEMPT DISTRIBUTION EXCLUDING SCHEDULE 1 OF 45-106F1

SEDAR ·  Jan 14, 2023 08:58
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.